Here’s an ETF to Invest in Immunotherapy–the Game Changing Cancer Treatment – Nasdaq
Nasdaq |
Here's an ETF to Invest in Immunotherapy–the Game Changing Cancer Treatment
Nasdaq In this episode of ETF Spotlight, I talked with Brad Loncar, CEO of Loncar Investments, who created the Loncar Cancer Immunotherapy Index, the underlying benchmark for the Loncar Cancer Immunotherapy ETF CNCR . Immunotherapy is often called a game … |
